We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Rimini Street
RMNI
$471M
| $160K | ﹤0.01% |
17,860
-840
| -4% | -$6.5K |
|
2877
Voyager Therapeutics
VYGR
$201M
| $160K | ﹤0.01% |
33,868
-1,300
| -4% | -$8.86K |
|
2878
Genasys
GNSS
$79.2M
| $159K | ﹤0.01% |
23,730
-1,620
| -6% | -$11.8K |
|
|
CLPR
2879
Clipper Realty
CLPR
$46.2M
| $158K | ﹤0.01% |
19,910
-2,794
| -12% | -$21.6K |
|
|
MBII
2880
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $157K | ﹤0.01% |
75,142
+100
| +0.1% | +$208 |
|
2881
Talphera
TLPH
$74.2M
| $155K | ﹤0.01% |
4,548
+152
| +3% | +$6.03K |
|
|
VIA
2882
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $155K | ﹤0.01% |
2,894
| – | – |
|
|
SREV
2883
DELISTED
ServiceSource International, Inc.
SREV
| $154K | ﹤0.01% |
104,803
+100
| +0.1% | +$165 |
|
2884
Alpha Pro Tech
APT
$53.1M
| $153K | ﹤0.01% |
15,631
+625
| +4% | +$8.29K |
|
2885
Retractable Technologies
RVP
$20.1M
| $153K | ﹤0.01% |
11,904
-220
| -2% | -$3.18K |
|
2886
Universal Technical Institute
UTI
$1.59B
| $152K | ﹤0.01% |
26,060
| – | – |
|
2887
Pioneer Bancorp
PBFS
$434M
| $150K | ﹤0.01% |
12,878
| – | – |
|
|
REV
2888
DELISTED
Revlon, Inc.
REV
| $150K | ﹤0.01% |
12,158
+25
| +0.2% | +$291 |
|
|
FNCB
2889
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $148K | ﹤0.01% |
19,601
-890
| -4% | -$6.39K |
|
2890
Fulcrum Therapeutics
FULC
$297M
| $146K | ﹤0.01% |
12,355
+490
| +4% | +$6.06K |
|
2891
Savara
SVRA
$1.19B
| $146K | ﹤0.01% |
70,148
-700
| -1% | -$1.2K |
|
|
AVEO
2892
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $146K | ﹤0.01% |
20,004
+73
| +0.4% | +$630 |
|
2893
Custom Truck One Source
CTOS
$2.37B
| $144K | ﹤0.01% |
15,359
-100
| -0.6% | -$815 |
|
2894
BeyondSpring
BYSI
$35.8M
| $142K | ﹤0.01% |
12,793
+230
| +2% | +$2.97K |
|
2895
Ponce Financial Group
PDLB
$485M
| $141K | ﹤0.01% |
17,666
-837
| -5% | -$6.36K |
|
|
PCTI
2896
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $141K | ﹤0.01% |
20,219
-860
| -4% | -$6.58K |
|
|
ALR
2897
DELISTED
AlerisLife Inc
ALR
| $139K | ﹤0.01% |
22,647
+550
| +2% | +$3.97K |
|
|
RESN
2898
DELISTED
Resonant Inc.
RESN
| $139K | ﹤0.01% |
32,836
-2,270
| -6% | -$12.2K |
|
2899
Orion Energy Systems
OESX
$80.6M
| $138K | ﹤0.01% |
1,980
-131
| -6% | -$12.2K |
|
|
AGRX
2900
DELISTED
Agile Therapeutics
AGRX
| $138K | ﹤0.01% |
33
-2
| -6% | -$10.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.